Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

DVAX – Dynavax Technologies Corporation

Dynavax Technologies Corporatio
DVAX
$11.02
Name : Dynavax Technologies Corporatio
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $1,444,104,960.00
EPSttm : 0.13
finviz dynamic chart for DVAX
Dynavax Technologies Corporatio
$11.02
1.52%
$0.17

Fair Value

9.8

Margin Of Safety %

-11

Put/Call OI Ratio

0.3

Float Short​ %​

13.84

EPS 1 Diff

-0.04

EPS Year Diff

0.24

Ticker: DVAX




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-09-06DVAX11.070.271.678908
2024-09-09DVAX10.810.273.078911
2024-09-10DVAX11.190.280.369027
2024-09-11DVAX10.90.280.009149
2024-09-12DVAX10.970.280.079258
2024-09-13DVAX11.180.280.009264
2024-09-16DVAX11.130.280.129266
2024-09-17DVAX11.270.281.769280
2024-09-18DVAX11.220.291.019352
2024-09-19DVAX11.50.330.5910323
2024-09-20DVAX11.360.330.0210356
2024-09-23DVAX11.120.310.719564
2024-09-24DVAX10.890.310.059589
2024-09-25DVAX10.780.310.019633
2024-09-26DVAX10.860.290.239787
2024-09-27DVAX11.010.290.059803
2024-09-30DVAX11.140.292.259859
2024-10-01DVAX11.310.300.0210027
2024-10-02DVAX11.360.300.0210079
2024-10-03DVAX11.190.300.0010160
2024-10-04DVAX11.020.300.2210172
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-09-06DVAX11.0320.0- 0.19
2024-09-09DVAX10.8820.0- 0.19
2024-09-10DVAX11.1920.0- 0.19
2024-09-11DVAX10.9020.0- 0.19
2024-09-12DVAX10.9620.0- 0.19
2024-09-13DVAX11.1720.0- 0.19
2024-09-16DVAX11.1420.0- 0.19
2024-09-17DVAX11.2720.0- 0.19
2024-09-18DVAX11.2120.0- 0.19
2024-09-19DVAX11.5020.0- 0.19
2024-09-20DVAX11.3520.0- 0.19
2024-09-23DVAX11.1220.0- 0.19
2024-09-24DVAX10.8820.0- 0.19
2024-09-25DVAX10.7820.0- 0.19
2024-09-26DVAX10.8520.0- 0.19
2024-09-27DVAX11.0020.0- 0.19
2024-09-30DVAX11.1420.0- 0.19
2024-10-01DVAX11.3220.0- 0.19
2024-10-02DVAX11.3620.0- 0.19
2024-10-03DVAX11.2020.0- 0.19
2024-10-04DVAX11.0220.0- 0.19
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-09-06DVAX-0.56-1.8114.51
2024-09-09DVAX-0.56-1.8114.51
2024-09-10DVAX-0.56-1.8114.51
2024-09-11DVAX-0.56-1.8114.51
2024-09-12DVAX-0.56-1.8114.03
2024-09-13DVAX-0.56-1.8114.03
2024-09-16DVAX-0.56-1.8114.03
2024-09-17DVAX-0.56-1.8114.03
2024-09-18DVAX-0.56-1.8114.03
2024-09-19DVAX-0.56-1.8114.03
2024-09-20DVAX-0.56-1.8114.03
2024-09-23DVAX-0.56-1.8114.03
2024-09-24DVAX-0.56-1.8114.03
2024-09-25DVAX-0.56-1.8113.84
2024-09-26DVAX-0.56-1.8113.84
2024-09-27DVAX-0.56-1.8113.84
2024-09-30DVAX-0.56-1.8113.84
2024-10-01DVAX-0.56-1.8113.84
2024-10-02DVAX-0.56-1.8113.84
2024-10-03DVAX-0.56-1.8113.84
2024-10-04DVAX-0.56-1.8113.84
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.08

Avg. EPS Est. Current Quarter

0.12

Avg. EPS Est. Next Quarter

0.04

Insider Transactions

-0.56

Institutional Transactions

-1.81

Beta

1.35

Average Sales Estimate Current Quarter

85

Average Sales Estimate Next Quarter

71

Fair Value (Academic)

11.17

Quality Score

75

Growth Score

51

Sentiment Score

90

Actual DrawDown %

48.5

Max Drawdown 5-Year %

-68.1

Target Price

24.5

P/E

100.82

Forward P/E

29.91

PEG

P/S

5.78

P/B

2.25

P/Free Cash Flow

40.87

EPS

0.11

Average EPS Est. Cur. Y​

0.19

EPS Next Y. (Est.)

0.37

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

6.88

Relative Volume

0.7

Return on Equity vs Sector %

-18.9

Return on Equity vs Industry %

-9.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Dynavax Technologies Corporatio
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 408
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.
stock quote shares DVAX – Dynavax Technologies Corporation Stock Price stock today
news today DVAX – Dynavax Technologies Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch DVAX – Dynavax Technologies Corporation yahoo finance google finance
stock history DVAX – Dynavax Technologies Corporation invest stock market
stock prices DVAX premarket after hours
ticker DVAX fair value insiders trading